DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Cyclopenthiazide

Cyclopenthiazide

  • Health Reports for Mutual Recognition of Medical Prescriptions: State of Play

    Health Reports for Mutual Recognition of Medical Prescriptions: State of Play

  • Comprehensive Screening of Diuretics in Human Urine Using Liquid Chromatography Tandem Mass Spectrometry

    Comprehensive Screening of Diuretics in Human Urine Using Liquid Chromatography Tandem Mass Spectrometry

  • DIURETICS Diuretics Are Drugs That Promote the Output of Urine Excreted by the Kidneys

    DIURETICS Diuretics Are Drugs That Promote the Output of Urine Excreted by the Kidneys

  • Extracts from PRAC Recommendations on Signals Adopted at the 9-12 March 2020 PRAC

    Extracts from PRAC Recommendations on Signals Adopted at the 9-12 March 2020 PRAC

  • Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

    Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set

  • PAPERS BMJ: First Published As 10.1136/Bmj.297.6641.95 on 9 July 1988

    PAPERS BMJ: First Published As 10.1136/Bmj.297.6641.95 on 9 July 1988

  • SOME ASPECTS of DIURETIC ACTIVITY of CYCLOPENTHIAZIDE and EFFECT of SPIRONOLAC [ONE on THEM, COMPARED with MERSALYL By

    SOME ASPECTS of DIURETIC ACTIVITY of CYCLOPENTHIAZIDE and EFFECT of SPIRONOLAC [ONE on THEM, COMPARED with MERSALYL By

  • Diuretics and Other Therapies for Hospitalized Heart

    Diuretics and Other Therapies for Hospitalized Heart

  • Evidence Review G: Step 4 Treatment

    Evidence Review G: Step 4 Treatment

  • Hyperuricemia Induced by Some Antihypertensives and Uricosuric Drugs in Oxonate-Treated Rats

    Hyperuricemia Induced by Some Antihypertensives and Uricosuric Drugs in Oxonate-Treated Rats

  • Change Notification No 9

    Change Notification No 9

  • And Ethacrynic Acid

    And Ethacrynic Acid

  • Section B Changed Classes/Guidelines Final Version Date of Issue

    Section B Changed Classes/Guidelines Final Version Date of Issue

  • Pharmaceuticals (Monocomponent Products) ………………………..………… 31 Pharmaceuticals (Combination and Group Products) ………………….……

    Pharmaceuticals (Monocomponent Products) ………………………..………… 31 Pharmaceuticals (Combination and Group Products) ………………….……

  • Impact of Risk Minimisation in Patients Treated with Rosiglitazone-Containing Products Commissioned by the European Medicines Ag

    Impact of Risk Minimisation in Patients Treated with Rosiglitazone-Containing Products Commissioned by the European Medicines Ag

  • Use of Diuretics in Cardiovascular Disease: (2) Hypertension S U Shah, S Anjum, W a Littler

    Use of Diuretics in Cardiovascular Disease: (2) Hypertension S U Shah, S Anjum, W a Littler

  • Diuretics in the Treatment of Patients Who Present Congestive Heart Failure and Hypertension

    Diuretics in the Treatment of Patients Who Present Congestive Heart Failure and Hypertension

  • Drugs Thought to Be Safe in Porphyria

    Drugs Thought to Be Safe in Porphyria

Top View
  • Drugs, Including Alcohol, That Act As Risk Factors for Cataract, and Possible Protection Against Cataract by Aspirin-Like Analgesics and Cyclopenthiazide
  • READY: Relative Efficacy of Loop Diuretics in Patients with Chronic Systolic Heart Failure—A Systematic Review and Network Meta-Analysis of Randomised Trials
  • ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
  • Of 33 Appendix
  • Diuretics in the Therapy of Hypertension
  • NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
  • First-Line Combination Therapy Versus First-Line Monotherapy for Primary Hypertension (Review)
  • WO 2016/133803 Al 25 August 2016 (25.08.2016) P O P C T
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • Chlorthalidone Combinations Chlorthalidon-Kombinationen Combinaisons De Chlorthalidone
  • The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
  • Recurrent Pancreatitis After Treatment with Hydrochlorothiazide
  • Thiazide and Thiazide-Like Diuretics
  • An Application to Include Blood Pressure Lowering Drug Fixed Dose
  • Thiazide-Induced Hyperglycaemia: a Role for Calcium-Activated Potassium Channels?
  • TA 9L MID 0 THB HISTAMINE [N CFD GASTRIC Secretolly RESPONSE in PIGEO S
  • Controlled Inpatient Study of Tienilic Acid in Treatment Ofgout and Hypertension 369
  • United States Patent (10) Patent No.: US 8,686,184 B2


© 2024 Docslib.org    Feedback